356 related articles for article (PubMed ID: 21868452)
21. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.
Koole C; Wootten D; Simms J; Savage EE; Miller LJ; Christopoulos A; Sexton PM
J Biol Chem; 2012 Feb; 287(6):3659-73. PubMed ID: 22147709
[TBL] [Abstract][Full Text] [Related]
22. Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus.
Runge S; Gram C; Brauner-Osborne H; Madsen K; Knudsen LB; Wulff BS
J Biol Chem; 2003 Jul; 278(30):28005-10. PubMed ID: 12724331
[TBL] [Abstract][Full Text] [Related]
23. Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.
Swedberg JE; Schroeder CI; Mitchell JM; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Price DA; Liras S; Craik DJ
J Biol Chem; 2016 Jul; 291(30):15778-87. PubMed ID: 27226591
[TBL] [Abstract][Full Text] [Related]
24. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
25. Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.
Moon MJ; Kim HY; Park S; Kim DK; Cho EB; Park CR; You DJ; Hwang JI; Kim K; Choe H; Seong JY
J Biol Chem; 2012 Feb; 287(6):3873-84. PubMed ID: 22105074
[TBL] [Abstract][Full Text] [Related]
26. A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.
Beinborn M; Worrall CI; McBride EW; Kopin AS
Regul Pept; 2005 Aug; 130(1-2):1-6. PubMed ID: 15975668
[TBL] [Abstract][Full Text] [Related]
27. Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.
Wilmen A; Van Eyll B; Göke B; Göke R
Peptides; 1997; 18(2):301-5. PubMed ID: 9149304
[TBL] [Abstract][Full Text] [Related]
28. The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists.
Al-Sabah S; Donnelly D
FEBS Lett; 2003 Oct; 553(3):342-6. PubMed ID: 14572647
[TBL] [Abstract][Full Text] [Related]
29. Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket.
Mann RJ; Al-Sabah S; de Maturana RL; Sinfield JK; Donnelly D
Peptides; 2010 Dec; 31(12):2289-93. PubMed ID: 20869417
[TBL] [Abstract][Full Text] [Related]
30. Isolation and structure-function studies of a glucagon-like peptide 1 receptor from goldfish Carassius auratus: identification of three charged residues in extracellular domains critical for receptor function.
Yeung CM; Mojsov S; Mok PY; Chow BK
Endocrinology; 2002 Dec; 143(12):4646-54. PubMed ID: 12446592
[TBL] [Abstract][Full Text] [Related]
31. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
32. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY
Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
[TBL] [Abstract][Full Text] [Related]
33. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.
Dods RL; Donnelly D
Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711
[TBL] [Abstract][Full Text] [Related]
34. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
Van Eyll B; Göke B; Wilmen A; Göke R
Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
[TBL] [Abstract][Full Text] [Related]
35. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
[TBL] [Abstract][Full Text] [Related]
36. Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.
Chepurny OG; Matsoukas MT; Liapakis G; Leech CA; Milliken BT; Doyle RP; Holz GG
J Biol Chem; 2019 Mar; 294(10):3514-3531. PubMed ID: 30622136
[TBL] [Abstract][Full Text] [Related]
37. Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.
Kirkpatrick A; Heo J; Abrol R; Goddard WA
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19988-93. PubMed ID: 23169631
[TBL] [Abstract][Full Text] [Related]
38. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
39. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
40. Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states.
Neidigh JW; Fesinmeyer RM; Prickett KS; Andersen NH
Biochemistry; 2001 Nov; 40(44):13188-200. PubMed ID: 11683627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
